Skip to main navigation Skip to search Skip to main content

A novel 6-benzyl ether benzoxaborole is active against mycobacterium tuberculosis in vitro

  • Nipul Patel
  • , Theresa O’Malley
  • , Yong Kang Zhang
  • , Yi Xia
  • , Bjorn Sunde
  • , Lindsay Flint
  • , Aaron Korkegian
  • , Thomas R. Ioerger
  • , Jim Sacchettini
  • , M. R.K. Alley
  • , Tanya Parish
  • Infectious Disease Research Institute
  • Pfizer
  • Texas A&M University

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

We identified a novel 6-benzyl ether benzoxaborole with potent activity against Mycobacterium tuberculosis. The compound had an MIC of 2 μM in liquid medium. The compound was also able to prevent growth on solid medium at 0.8 μM and was active against intracellular bacteria (50% inhibitory concentration [IC50] 3.6 μM) without cytotoxicity against eukaryotic cells (IC50 100 μM). We isolated resistant mutants (MIC ≥ 100 μM), which had mutations in Rv1683, Rv3068c, and Rv0047c.

Original languageEnglish
Article numbere01205-17
JournalAntimicrobial Agents and Chemotherapy
Volume61
Issue number9
Early online date24 Aug 2017
DOIs
Publication statusPublished - 1 Sept 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antimicrobial
  • Antitubercular
  • Drug resistance

Fingerprint

Dive into the research topics of 'A novel 6-benzyl ether benzoxaborole is active against mycobacterium tuberculosis in vitro'. Together they form a unique fingerprint.

Cite this